Molecular analyses and clinical application of a novel oncogene, SMYD2 in gastrointestinal cancers.
| Project/Area Number |
22890158
|
|---|
| Research Category |
Grant-in-Aid for Research Activity Start-up
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Digestive surgery
|
|---|
| Research Institution | Kyoto Prefectural University of Medicine |
|---|
Principal Investigator |
KOMATSU Shuhei 京都府立医科大学, 医学研究科, 助教 (40578978)
|
|---|
| Project Period (FY) |
2010 – 2011
|
| Project Status |
Completed (Fiscal Year 2011)
|
| Budget Amount *help |
¥3,068,000 (Direct Cost: ¥2,360,000、Indirect Cost: ¥708,000)
Fiscal Year 2011: ¥1,469,000 (Direct Cost: ¥1,130,000、Indirect Cost: ¥339,000)
Fiscal Year 2010: ¥1,599,000 (Direct Cost: ¥1,230,000、Indirect Cost: ¥369,000)
|
|---|
| Keywords | 分子生化学 / 分子標的 / 癌遺伝子 / 分子生物学 |
|---|
| Research Abstract |
Previously, we detected the novel cancer-related gene, SMYD2(SET and MYND domain-containing protein 2) as a novel amplification target of 1q32-41 in esophageal squamous cell carcinoma(Komatsu S et al. Carcinogenesis 2009). In this study, we demonstrated the molecular mechanisms and clinical significance of SMYD2 in gastrointestinal cancers, especially in gastric carcinoma.
|
Report
(3 results)
Research Products
(9 results)
